Our mission

The Portland Institute for Psychedelic Science (PIPS) is dedicated to advancing the field of psychedelic research and therapies. We seek to better understand and refine the therapeutic potential of psychedelics through rigorous scientific research, to offer transformative psychedelic-assisted therapies grounded in evidence-based practices, and to cultivate excellence among psychedelic-assisted therapy providers through our specialized training programs. Committed to healing and innovation, we strive to advance the standard for efficacy and integrity in psychedelic science and services across the region. 

What we do

What makes us unique

Our experience in conducting psychedelic research, providing psychedelic-assisted therapy, and educating other professionals under one roof provides a range of benefits. Our ability to comprehensively integrate knowledge from research evidence and applied practice creates a feedback loop between research and practice that continually enhances each facet of our work. This synergy allows for the rapid translation of research findings into practical therapeutic techniques, ensuring that our services are always at the cutting edge of the field. Furthermore, our multifaceted approach fosters a rich learning environment for professionals, enhancing their skills and understanding of psychedelic science in a way that an institution with a narrower focus cannot. This inclusive and integrative model not only sets a high standard for treatment efficacy and professional training but also positions us as a leader in the field, contributing significantly to the advancement of psychedelic science and its acceptance in mainstream healthcare.

What we have to say

Featured
New Study Compares Attitudes Toward Psychedelic Therapy Across Mental Health Disciplines 
New Study Compares Attitudes Toward Psychedelic Therapy Across Mental Health Disciplines 

As the field of psychedelic-assisted therapy (PAT) continues to grow, it is essential to understand how different mental health professionals perceive this emerging treatment modality. A recent study coauthored by Portland Insitute of Psychedelic Science’s (PIPS) Jason Luoma, Ph.D. and Brian Pilecki, Ph.D., sheds light on the varied attitudes and beliefs held by social workers, psychologists, and psychiatrists in the United States regarding PAT. 

Attitudes Toward Psychedelic-Assisted Therapy: Insights from U.S. Psychologists
Attitudes Toward Psychedelic-Assisted Therapy: Insights from U.S. Psychologists

Psychedelic-assisted therapy (PAT) is gaining momentum as a promising approach for treating various mental health conditions, from depression to substance use disorders. However, as the field of psychedelic research expands, it is crucial to understand the perspectives of those who may be at the forefront of implementing these treatments: clinical psychologists.

The Importance of Touch in MDMA-Assisted Therapy: Insights from Recent Research 
The Importance of Touch in MDMA-Assisted Therapy: Insights from Recent Research 

MDMA-assisted therapy (MDMA-AT) appears to be on the way to becoming a legally recognized treatment for conditions such as post-traumatic stress disorder (PTSD). Researchers are diving deeper into understanding the nuances of this therapeutic approach, including the role of physical touch in therapy sessions.

The Role of Group-Administered Psilocybin in Enhancing Psychological Flexibility
The Role of Group-Administered Psilocybin in Enhancing Psychological Flexibility

As the field of psychedelic-assisted therapy (PAT) continues to evolve, researchers are increasingly interested in understanding the underlying processes that contribute to its therapeutic effects. A recent pilot study conducted by a team of researchers from Portland Psychotherapy, including Brian Pilecki, Ph.D., and Jason Luoma, Ph.D., provides valuable insights into how psilocybin, administered in a group setting, influences psychological flexibility—a core concept in mental health and behavioral change.